Gro Østli Eilertsen
Thao Nguyen,
Ingrid Hokstad,
Morten Fagerland,
Tom Eirik Mollnes,
Ivana Hollan,
Mark W. Feinberg
et al.:
Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
Warren David Raymond,
Matthew Hamdorf,
Michael Furfaro,
Gro Ostli Eilertsen,
Hans Nossent
:
Smoking associates with increased BAFF and decreased interferon-γlevels in patients with systemic lupus erythematosus
Thao Nguyen,
Morten Fagerland,
Gia Deyab,
Gunnbjørg Hjeltnes,
Ivana Hollan,
Mark W. Feinberg
et al.:
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
Sharma Chanakya,
Warren David Raymond,
Gro Østli Eilertsen,
Hans Nossent
:
Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus
Warren David Raymond,
Gro Østli Eilertsen,
Sharanyaa Shanmugakumar,
Hans Nossent
:
The impact of cytokines on the health-related quality of life in patients with systemic lupus erythematosus
Hege Lynum Pedersen,
Kjersti Daae Horvei,
Dhivya Thiyagarajan,
Gudrun Norby,
Natalya Seredkina,
Gabriella Moroni
et al.:
Lupus nephritis: low urinary DNase I levels reflect loss of
renal DNase I and may be utilized as a biomarker of
disease progression
Seyed Esmaeil Dorraji,
Aud-Malin Karlsson Hovd,
Premasany Kanapathippillai,
Gunnstein Bakland,
Gro Østli Eilertsen,
Stine Figenschau
et al.:
Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis
Warren David Raymond,
Gro Østli Eilertsen,
Johannes Nossent
:
Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.
Cytokine 11. Dec 2018 DOI
Warren David Raymond,
Gro Østli Eilertsen,
Johannes Nossent
:
Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus
Heather Jones,
Warren David Raymond,
Gro Østli Eilertsen,
Johannes Nossent
:
The role of soluble erythropoietin receptors inanaemia of chronic disease in SLE and RA
International Journal of Rheumatic Diseases 06. Sep 2018 DOI
Heather Jones,
Warren David Raymond,
Gro Østli Eilertsen,
Johannes Nossent
:
Soluble erythropoietin receptor levels
associate with inflammatory mediators
but not with disease activity or cumulative
organ damage in patients with systemic
lupus erythematosus
J Waldron,
Warren Raymond,
Gro Østli Eilertsen,
Hans Nossent
:
Insulin-like growth factor-1 (IGF1) in systemic lupus
erythematosus: relation to disease activity, organ damage
and immunological findings
Lupus 2018 DOI
Warren D Raymond,
Gro Østli Eilertsen,
Sheynae Griffiths,
Hans Nossent
:
IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.
European Journal of Rheumatology 2017 DOI
Michele Compagno,
Birgitta Gullstrand,
Søren Jacobsen,
Gro Østli Eilertsen,
Jan Åke Nilsson,
Christian Lood
et al.:
The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: An observational longitudinal study
Hans Nossent,
Warren D Raymond,
Gro Østli Eilertsen
:
Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.
Lupus Science and Medicine 2016 DOI
Gro Østli Eilertsen,
Hans Nossent
:
APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus
Lupus 2014 DOI
Michele Compagno,
Ole Petter Rekvig,
Anders Bengtsson,
Gunnar Sturfeld,
Niels H. H. Heegaard,
Andreas Jönsen
et al.:
Clinical phenotype associations with various types of anti-dsDNA antibodies in patients with recent onset of rheumatic symptoms. Results from a multicentre observational study
Michele Compagno,
S. Jacobsen,
Ole Petter Rekvig,
L. Truedsson,
Niels H. H. Heegaard,
Johannes C Nossent
et al.:
Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study
Scandinavian Journal of Rheumatology 2013 DOI
Andrea Becker-Merok,
Gro Østli Eilertsen,
S Lester,
Johannes C Nossent
:
Circulating interferon-alpha 2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation
Lupus 2013 DOI
Gro Østli Eilertsen,
Marijke Van Ghelue,
Johannes C Nossent
:
BAFF expression is increased in Lupus Nephritis and associated with activation of C1 inhibitor, α-1-acid-glycoprotein and endothelial markers
Gro Østli Eilertsen
:
Cytokiner ved SLE
BestPractice Norge 2012
Gro Østli Eilertsen,
Silje Fismen,
Tor-Arne Hanssen,
Johannes C Nossent
:
Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy
Nephrology, Dialysis and Transplantation 2011 DOI
Gro Østli Eilertsen,
Marijke Van Ghelue,
Harald Strand,
Johannes C Nossent
:
Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study
Rheumatology 2011 DOI
Gro Østli Eilertsen,
Cathrin Nikolaisen,
Andrea Becker-Merok,
Johannes C Nossent
:
Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus
Lupus 2011 DOI
Andrea Becker-Merok,
Gro Østli Eilertsen,
Johannes C Nossent
:
Levels of Transforming Growth Factor-beta Are Low in Systemic Lupus Erythematosus Patients with Active Disease
Journal of Rheumatology 2010 DOI
Gro Østli Eilertsen,
Silje Fismen,
Tor-Arne Hanssen,
Johannes C Nossent
:
Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy
Nephrology, Dialysis and Transplantation 2010 DOI
Gro Østli Eilertsen,
Andrea Becker-Merok,
Johannes C Nossent
:
The Influence of the 1997 Updated Classification Criteria for Systemic Lupus Erythematosus: Epidemiology, Disease Presentation, and Patient Management
Gro Østli Eilertsen,
Nikolaos Panagiotopoulos,
Tor Arnøy Austad,
Thomas Glott
:
En mann i 60-arene med akutte ryggsmerter og økende kraftsvikt i underekstremitetene
2020
Hege Lynum Pedersen,
Kjersti Daae Horvei,
Dhivya Thiyagarajan,
Gudrun Norby,
Natalya Seredkina,
Gabriella Moroni
et al.:
LUPUS NEPHRITIS: SEVERELY REDUCED URINARY DNASE I LEVELS REFLECT LOSS OF RENAL DNASE I, DISEASE PROGRESSION AND MAY REDUCE THE NEED FOR RENAL BIOPSIES
2018
Chanakya Sharma,
Warren David Raymond,
Gro Østli Eilertsen,
Johannes Nossent
:
LUPUS LOW DISEASE ACTIVITY STATE (LLDAS-50) IS
A SIGNIFICANT PREDICTOR FOR DAMAGE ACCRUAL
AND MORTALITY: A NORWEGIAN COHORT ANALYSIS
Annals of the Rheumatic Diseases 12. Jun 2018 DOI
Hans Nossent,
Warren Raymond,
Gro Østli Eilertsen
:
The functional state of Von Willebrand Factor is not increased in patients with Systemic Lupus Erythematosus.
2016
Gro Østli Eilertsen,
Lise Balteskard
:
Infeksiøs endokarditt i Helse Nord
2014
Gro Østli Eilertsen,
Marijke van Ghelue,
Harald Strand,
Johannes C Nossent
:
Increased BAFF in Lupus Nephritis is unrelated to histological severity, but associates with acute-phase reactants and endothelial activation markers
2012
michele compagno,
Søren Jacobsen,
Ole Petter Rekvig,
Lennart Truedsson,
Niels H. H. Heegaard,
Johannes C Nossent
et al.:
Diagnostic Accuracy of Anti-dsDNA Antibodies in Unselected Patients with Recent Onset of Rheumatic Symptoms
Arthritis and Rheumatism 2012
Gro Østli Eilertsen,
Iren Eide Helland,
Ingunn M Gundersen,
Johannes C Nossent
:
BAFF and APRIL activaion associate with different immunologic pathways in patients with SLR
2012
Gro Østli Eilertsen,
Johannes C Nossent
:
BAFF AND APRIL ACTIVATION ASSOCIATE WITH DIFFERENT IMMUNOLOGIC PATHWAYS IN PATIENTS WITH SLE
Scandinavian Journal of Rheumatology. Supplement 2012
Gro Østli Eilertsen,
Johannes C Nossent
:
BAFF and APRIL activation is associated with different immunological pathways in patients with SLE
Scandinavian Journal of Rheumatology 2012
Gro Østli Eilertsen
:
Anti-CD22 - utprøving av et nytt medikament mot SLE
BestPractice 2011
Johannes C Nossent,
Maureen Rischmueller,
Sue Lester,
Gro Østli Eilertsen
:
Increased BAFF levels in patients with SLE correlate with acute phase reactants independent of gene polymorphism or expression
2011
Gro Østli Eilertsen,
Marijke Van Ghelue,
Harald Strand,
Johannes C Nossent
:
INCREASED LEVELS OF BAFF IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS MIRROR ACUTE PHASE REACTANTS AND ARE INDEPENDENT OF BAFF PROMOTER GENOTYPE OR EXPRESSION IN PERIPHERAL BLOOD CELLS
Internal Medicine Journal 2011
Gro Østli Eilertsen
:
SLE-forskning BAFF og nyresykdom
Revmatikeren 2011
Andrea Becker-Merok,
Gro Østli Eilertsen,
Johannes C Nossent
:
LOW TRANSFORMING GROWTH FACTOR BETA LEVELS IN LUPUS PATIENTS WITH ACTIVE DISEASE
Scandinavian Journal of Rheumatology 2010
Gro Østli Eilertsen,
Marijke Van Ghelue,
Harald Strand,
Johannes C Nossent
:
CIRCULATING B-CELL ACTIVATING FACTOR IN PATIENTS WITH SLE CORRELATES WITH MARKERS OF INFLAMMATION BUT NOT WITH POLYMORPHISMS IN THE 5 ' REGULATORY REGION OF THE BAFF GENE OR MRNA EXPRESSION
Scandinavian Journal of Rheumatology. Supplement 2010
Gro Østli Eilertsen,
Marijke Van Ghelue,
Harald Strand,
Johannes C Nossent
:
B-cell activating factor levels correlate with acute phase reactants, but not with BAFF gene polymorphisms or BAFF gene expression in blood mononuclear cells in patients with Systemic Lupus Erythematosus: a case control study
2010
Gro Østli Eilertsen,
Andrea Becker-Merok,
kirsten synnØve Nilsen,
Johannes C Nossent
:
Anti-C1q antibody production in SLE is a measure of anti-dsDNA and antinuclesome antibody mediated hypocomplementemia independent of B-lymphocyte activating factor and organ involvement
Lupus 2008
Gro Østli Eilertsen,
Silje Fismen,
Tor-Arne Hanssen,
Johannes C Nossent
:
Lupus Nephritis in Northern Norway: reduced prevalence and improved renal prognosis during the last decade
Lupus 2008
Andrea Becker-Merok,
Gro Østli Eilertsen,
Johannes C Nossent
:
Disease specific determinants of long-term health-related quality of life in SLE
Lupus 2008 DOI
Gro Østli Eilertsen
:
Polymorfisme av BAFF-genet i relasjon til kliniske funn og autoantistoff ved sykddommen SLE
Revmatikeren 2008
Gro Østli Eilertsen,
Andrea Becker-Merok,
kirsten synnØve Nilsen,
Johannes C Nossent
:
Anti-C1q antibody production in SLE is a measure of anti-dsDNA and antinuclesome antibody mediated hypocomplementemia independent of B-lymphocyte activating factor and organ involvement
2008
Gro Østli Eilertsen,
Silje Fismen,
Tor-Arne Hanssen,
Johannes C Nossent
:
Lupus Nephritis in Northern Norway: reduced prevalence and improved renal prognosis during the last decade
2008
The 50 latest publications is shown on this page. See all publications in Cristin here →